Activella combined with Premarin

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Progesterone Receptor Assay Positive Other Serious 7/23/2003 51 Female 1/3/2006 United States
Primary
Secondary
Neoplasm Malignant Other Serious Female 1/11/2006 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious Female 1/13/2006 United States
Primary
Secondary
Depression Other Serious 1/1/2004 68 Female 121 lb 1/31/2006 Consumer United States
Primary
Secondary
Concomitant
Progesterone Receptor Assay Positive Other Serious 1/14/2002 54 Female 1/31/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 8/27/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 6/1/2003 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Weight Increased Other Serious 1/30/2003 66 Female 2/15/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 1/29/2004 62 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/2/2003 62 Female 12/23/2005 United States
Primary
Secondary
Pulmonary Embolism Other Serious 1/1/2003 52 Female 215 lb 12/23/2005 United States
Primary
Secondary
Myocardial Infarction Other Serious 1/1/1999 Female 2/27/2006 United States
Primary
Secondary
Breast Cancer Female Death Female 2/28/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 2/24/2006 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious Female 3/6/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 10/1/2002 57 Female 3/10/2006 Physician United States
Primary
Secondary
Breast Cancer Female Other Serious 2/17/2004 Female 3/21/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/2/2001 64 Female 4/11/2006 Lawyer United States
Primary
Secondary
Smear Cervix Abnormal Other Serious 5/9/2002 54 Female 153 lb 4/5/2006 Lawyer United States
Primary
Secondary
Concomitant
Wound Infection Staphylococcal Other Serious 1/30/2003 66 Female 4/14/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 8/27/2003 Female 2/8/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 6/2/2001 64 Female 4/12/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 5/1/2004 Female 4/13/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 5/1/2004 Female 4/19/2006 Lawyer United States
Primary
Secondary
Neoplasm Malignant Other Serious 6/11/2004 62 Female 6/16/2006 Consumer United States
Primary
Secondary
Neoplasm Malignant Other Serious 6/11/2004 62 Female 6/21/2006 United States
Primary
Secondary
Uterine Leiomyoma Hospitalization 5/9/2002 54 Female 153 lb 6/29/2006 Lawyer United States
Primary
Secondary
Concomitant
Weight Increased Other Serious 6/12/2003 63 Female 180 lb 6/22/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 3/1/2003 59 Female 7/10/2006 United States
Primary
Secondary
Breast Cancer Required Intervention Female 6/15/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious Female 7/7/2006 United States
Primary
Secondary
Breast Cancer Other Serious 6/1/2003 Female 7/7/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 7/7/2006 United States
Primary
Secondary
Breast Cancer Metastatic Required Intervention Female 7/7/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 6/2/2001 64 Female 7/7/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 5/1/2004 Female 7/7/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 11/15/2003 Female 7/7/2006 United States
Primary
Secondary
Breast Cancer Required Intervention 4/2/2003 56 Female 7/7/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 7/23/2003 51 Female 7/7/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2004 Female 7/7/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2003 Female 7/7/2006 United States
Primary
Secondary
Breast Cancer Required Intervention 6/18/2003 55 Female 7/7/2006 United States
Primary
Secondary
Breast Cancer Required Intervention 4/1/2001 54 Female 7/7/2006 United States
Primary
Secondary
Breast Cancer Other Serious 8/1/2003 67 Female 7/7/2006 United States
Primary
Secondary
Breast Cancer Other Serious 7/30/2003 57 Female 141 lb 7/7/2006 United States
Primary
Secondary
Concomitant
Breast Cancer Required Intervention 6/25/2003 55 Female 159 lb 7/7/2006 United States
Primary
Secondary
Concomitant
Breast Cancer In Situ Required Intervention 5/1/2003 56 Female 127 lb 7/7/2006 United States
Primary
Secondary
Breast Cancer Other Serious 9/15/2003 61 Female 7/7/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/17/2003 57 Female 217 lb 7/7/2006 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Required Intervention 1/14/2002 54 Female 145 lb 7/7/2006 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 7/1/2003 Female 7/7/2006 United States
Primary
Secondary
Breast Cancer Other Serious 8/27/2003 Female 7/7/2006 Consumer United States
Primary
Secondary
Breast Cancer Required Intervention 9/1/2003 Female 7/7/2006 United States
Primary
Secondary
Breast Cancer Hospitalization Female 7/21/2006 Lawyer United States
Primary
Secondary
Metastases To Lymph Nodes Other Serious 11/7/2002 56 Female 8/15/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 8/21/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 1/30/2003 Female 8/29/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 2/17/2004 56 Female 10/31/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 3/1/2003 59 Female 10/31/2006 Lawyer United States
Primary
Secondary
Breast Cancer In Situ Other Serious 6/28/2004 47 Female 10/31/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 11/1/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 5/1/2004 Female 155 lb 11/17/2006 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 10/25/2002 Female 11/17/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/25/2002 Female 11/14/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 10/25/2002 Female 11/15/2006 Lawyer United States
Primary
Secondary
Myocardial Infarction Other Serious 1/1/1999 Female 200 lb 11/29/2006 United States
Primary
Secondary
Concomitant
Oestrogen Receptor Assay Positive Required Intervention 11/7/2002 56 Female 180 lb 11/22/2006 Consumer United States
Primary
Secondary
Concomitant
Tricuspid Valve Incompetence Other Serious 1/1/1999 Female 200 lb 12/11/2006 United States
Primary
Secondary
Concomitant
Deep Vein Thrombosis Other Serious 8/9/2002 Female 220 lb 12/20/2006 Other Health Professional United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 12/1/2002 Female 12/13/2006 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 12/1/2002 Female 12/14/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 12/1/2002 Female 12/13/2006 Lawyer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 6/2/2001 Female 156 lb 12/30/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 12/30/2002 Female 1/5/2007 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2003 59 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 12/30/2002 Female 1/4/2007 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 11/14/2003 56 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer In Situ Other Serious 6/28/2004 47 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 2/17/2004 Female 195 lb 2/2/2007 Lawyer United States
Primary
Secondary
Concomitant
Papillary Serous Endometrial Carcinoma Other Serious 6/11/2006 Female 175 lb 2/2/2007 United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 9/4/2003 Female 125 lb 2/2/2007 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious Female 195 lb 2/2/2007 United States
Primary
Secondary
Concomitant
Pharmaceutical Product Complaint Other Serious 5/9/2002 Female 153 lb 2/8/2007 United States
Primary
Secondary
Concomitant
Progesterone Receptor Assay Positive Other Serious 5/27/2004 Female 166 lb 2/16/2007 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 6/1/2001 Female 165 lb 2/22/2007 United States
Primary
Secondary
Concomitant
Breast Cancer Hospitalization 12/30/2002 Female 175 lb 2/27/2007 Other Health Professional United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious Female 195 lb 3/6/2007 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 9/1/2003 Female 140 lb 4/6/2007 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 3/1/2003 59 Female 173 lb 4/6/2007 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 12/1/2001 54 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 6/30/2003 59 Female 155 lb 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 7/23/2003 51 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 11/14/2002 59 Female 165 lb 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/25/2002 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 5/1/2004 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 2/17/2004 56 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 10/1/2000 59 Female 156 lb 2/7/2007 Lawyer United States
Primary
Secondary
Weight Decreased Other Serious 1/1/2001 48 Female 134 lb 2/7/2007 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious Female 4/6/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary

Drug Data